INTRODUCTION
Classical swine fever virus (CSFV) is a key member of the genus Pestivirus of the family Flaviviridae. It has a single positive-stranded RNA genome of approximately 12.3 kb, containing a single large open reading frame encoding 3,898 amino acids, which are processed by viral and host proteases to produce 12 mature proteins, four structural proteins (C, Erns, E1, and E2) and eight non-structural proteins (NSPs) (N pro , p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) (BD et al., 2007) . CSFV or its proteins can hijack host signaling pathways and biosynthetic systems for viral replication via interaction between viral and host proteins. CSFV-E2 protein has been reported to promote viral replication by interacting with annexin 2 or by activating the MEK2/ERK1/2 signal transduction cascade Yang et al., 2015) , and E2 can also negatively regulate viral replication by interacting with thioredoxin 2 (Trx2) and activating nuclear factor (NF)-kB pathway (Li et al., 2015b) . CSFV-NS5A promotes viral replication and spreading by interaction with heat shock protein 70 (HSP70) or by localization within the endoplasmic reticulum (ER) where it induces oxidative stress in vascular endothelial cells He et al., 2012) . CSFV-NS5A can also inhibit internal ribosome entry site (IRES)-mediated translation by interaction with eukaryotic elongation factor 1A (eEF1A) (Li et al., 2015a) , whereas CSFV-NS3 interacts with TRAF6 and degrades it to promote CSFV replication via the NF-kB signaling pathway (Lv et al., 2017) , and CSFV-N pro interacts with interferon regulatory factor 3 (IRF-3) or IRF-7 and blocks type I interferon induction (Bauhofer et al., 2007; Fiebach et al., 2011) .
Mammalian target of rapamycin (mTOR), of the phosphatidylinositol kinase-related kinase family, usually acts as a crucial nutritional and cellular energy checkpoint sensor and mediator for cell growth, proliferation, and survival. Indeed, the mTOR complex 1 (mTORC1) kinase is the central node of a serial signaling pathway (Saxton and Sabatini, 2017) . Increasing studies have revealed that mTOR not only works as a master sensor of cellular homeostatic perturbations but also significantly contributes to viral infections (McNulty et al., 2013; Mannova and Beretta, 2005) . For example, hepatitis C virus (HCV) infection upregulates the activity of mTOR and blocking of mTOR potently inhibits HCV RNA replication (Stohr et al., 2016) . A similar mechanism is also operative during infection with human cytomegalovirus and human immunodeficiency virus (HIV) (Martin et al., 2012; Cinti et al., 2017) . In contrast, however, hepatitis B virus (HBV) or hepatitis E virus (HEV) downregulates the activity of mTOR pathway, and blocking mTOR facilitates their replication (Guo et al., 2007; Zhou et al., 2014) . In addition, inhibition of mTORC1 enhances the protein translation of chikungunya virus (CHIKV) by activating the Mnk/eukaryotic initiation factor-4E (eIF4E) pathway (Joubert et al., 2015) . Intriguingly, after infection of host cells with porcine reproductive and respiratory syndrome virus (PRRSV), mTOR has been shown to be upregulated initially but later downregulated, resulting in viral replication in a 4E-binding protein 1 (4E-BP1)-associated manner (Zhang and Wang, 2010) . These ongoing studies have shown that the Akt/mTOR pathway is involved in the replication of an increasing number of viruses through regulation of cell metabolic process, autophagy, and protein synthesis, but its role in the regulation of CSFV replication is unknown.
Autophagy is an intracellular degradation process that maintains the metabolic balance and homeostasis of cells by clearance and recycling of intercellular constituents (Jiang et al., 2015) . Previous studies have suggested that autophagy not only exerts a protective function in cellular survival under stress but also plays a role to facilitate or inhibit viral replication in various ways (Shintani and Klionsky, 2004; Levine and Kroemer, 2008; Deretic, 2010) . Viruses such as Zika (ZIKV), HCV, bovine viral diarrhea (BVDV), and dengue (DENV) have been found to hijack cellular autophagy to facilitate their replication (Liang et al., 2016; Dreux et al., 2009; Fu et al., 2014; Datan et al., 2016) , whereas herpes simplex virus type 1 (HSV-1) inhibits autophagy to facilitate its replication (Orvedahl et al., 2007) . Chen et al. have reported that CSFV developed autophagic machinery by interaction of its E2 protein with autophagosomes to favor viral growth and survival of host cells and that inhibition of autophagy significantly reduced viral proliferation. Cellular autophagy is regulated by multiple cellular signaling pathways, including Atg6/ Beclin-1, which forms a complex with Vps34, thereby recruiting other proteins to the complex and eventually promoting autophagy. However, the anti-apoptotic protein Bcl-2 inhibits autophagy by binding Beclin-1. Two ubiquitin-like conjugation processes also contribute to the autophagy by generating membrane-bound protein complexes. ULK1/Atg1, the key serine/threonine kinase in the core autophagy pathway, is activated in response to nutrient deprivation and serves as a critical initiator of starvationinduced autophagy. Normally, mTORC1 is an upstream kinase that can inactivate ULK1 by phosphorylating a single site, Ser757 (Egan et al., 2011) . Recent studies have shown that several viruses can induce autophagy in an mTOR-dependent manner Yin et al., 2017; Zhou et al., 2017) , although some cell types undergo autophagy without involvement of the ULK1 complex (Cheong et al., 2011) , presumably, at least in part, by direct signaling to the downstream Vps34/Beclin1 complex.
The mTOR pathway also plays a key role in regulating the translation of cellular and viral proteins through its downstream effectors such as p70S6 kinase1 (S6K1) and 4E-BPs. Normally in cap-dependent translation systems, mTOR directly activates S6K1 and 4E-BPs through phosphorylation, following which the activated 4E-BPs release the binding to eIF4E and promote the interaction of eIF4E with the cap structure of messenger RNA (mRNA). Alternatively, the activated mTOR binds to the eIF3 complex, resulting in the dissociation of S6K1 from eIF3 and activation of S6K1, which leads to the binding of eIF3 to the 40S subunit and stimulation of cap-dependent translation (Schepetilnikov et al., 2013; Hashem et al., 2013) . However, some RNA viruses without cap-structured 5 0 untranslated regions (UTR), including CSFV, have developed other mechanisms for their replication bypassing the cap-dependent translation (Leen et al., 2016; Matsuda and Mauro, 2014; Amorim et al., 2014; Hashem et al., 2013) . For example, an IRES located between nt 40 and 350 at the 5 0 UTR has been shown to mediate translation of the viral genome. This has a high degree of RNA secondary structure and recruits ribosomal 40S subunits in close proximity to the initiation codon in a cap-independent manner Friis et al., 2012; , IRES-mediated translation has a great advantage for viruses containing an IRES because viral proteins can be generated efficiently even in cells that undergo apoptosis or nutritional starvation (Hashem et al., 2013; Kolupaeva et al., 2000) . Recent findings have suggested that activated mTOR exhibits anti-viral activity in HCV, which processes a non-cap construction at the 5 0 end of the viral mRNA by inducing an association between eIF3 and eIF4G (Muraoka et al., 2012; Schepetilnikov et al., 2013) . Moreover, HCV and CSFV mRNAs contain related IRESs that promote 5 0 -end-independent initiation of translation, requiring only a subset of the eIFs needed for canonical initiation on cellular mRNAs (Schepetilnikov et al., 2013) . A cryoelectron microscopic reconstruction of a 40S ribosome complex containing eIF3 and the CSFV-IRES has been presented (Hashem et al., 2013) , in which eIF3 is completely displaced from its ribosomal position in the 43S complex and instead interacts through its ribosome binding surface exclusively with the apical region of domain III of the IRES. Holz et al. (Holz et al., 2005) then demonstrated that eIF3 family members, as S6K1 interactors, represented a potential important connection between the mTOR pathway and an integral component of the translational pre-initiation apparatus, with the activity of S6K1 negatively regulating its binding to eIF3. Mutants that eliminate S6K1 activity constitutively bind eIF3, whereas active S6K1 mutants are incapable of binding eIF3. However, whether the CSFV can benefit their protein synthesis through modifying the mTOR pathway remained unclear.
In this study, we have demonstrated cross talk between the mTORC1 signaling pathway and CSFV replication and have also disclosed the underlying mechanism by which mTORC1 contributes to viral replication. We also found that inhibition of the mTORC1 pathway induced by CSFV elicited a negative feedback activation of the PI3K/Akt/mTORC1 pathway, which contributed to maintaining the dynamic balance between viral replication and host cell survival. Collectively, our results provide strong evidence showing that the mTORC1 pathway plays a crucial role in regulating CSFV replication and cell survival.
RESULTS

CSFV Infection Inhibited the Activation of PI3K/AKT/mTORC1 Pathway
To investigate the impact of CSFV infection on the mTORC1 pathway, ST cells were infected with CSFV and subjected to PathScan intracellular signaling membrane array analysis. See Figure S1 for a detailed map of the proteins tested via the PathScan assay. Our results showed that the phosphorylation states of Akt (S473), mTORC1 (Ser 2448), and their downstream effectors GSK-3b (Ser9) and ribosomal protein S6 were significantly decreased in CSFV-infected cells within 24 hr post-infection (p.i.), but intriguingly, the phosphorylation level had recovered by 48 hr p.i. when compared with mock-infected controls ( Figure 1A ). To further investigate the impact of CSFV infection on mTORC1 activity, we examined the activity of Akt/ mTORC1 pathway proteins at different time points after CSFV infection by western blot. Results were consistent with the array analysis. CSFV infection suppressed the activity of Akt/mTORC1pathway, with protein activities bottoming around 12 hr p.i., followed by recovery to the basal level at 48 hr p.i. (Figure 1B ), whereas the levels of these proteins remained unchanged in mock-infected controls.
The CSFV genome encodes four structural and eight NSPs. To delineate the role of individual viral proteins in Akt/mTORC1 regulation, we transfected ST cells with several recombinant constructs encoding individual CSFV proteins, E rns , NS3, NS4B, and NS5A, all of which are involved in viral infection, replication, and virulence. The expression of each protein was detected at 48 hr p.i. after transfection. As shown in Figure 1C , expression of E rns , NS3, and NS5A increased the activity of Akt/mTORC1pathway, whereas transduced NS4B did not exhibit significant influence. These results indicate that CSFV proteins E rns , NS3, and NS5A play key roles in suppressing the activity of Akt/mTORC1 pathway, which implied a likely role for Akt/mTORC1 in CSFV replication.
Activation of Akt/TSC2/mTORC1 Pathway Inhibits CSFV Replication and Viral Production
To understand the role of mTORC1 in CSFV replication, we inhibited mTORC1 activity by rapamycin, which works as an allosteric inhibitor of mTORC1, or activated mTORC1 with insulin, which works as a major cytokine for protein synthesis and cell growth by activating the PI3K/Akt/mTORC1 signaling pathway (Muraoka et al., 2012) . As shown in Figure 2 , rapamycin potently inhibited the activity of mTORC1 pathway whether or not CSFV was present. Conversely, insulin not only moderately promoted the activity of mTORC1 in the absence of CSFV but also rescued its activity level in the presence of CSFV. As expected, ultraviolet (UV)-inactivated CSFV lost its capability to inhibit the activation of the mTORC1 pathway (Figure 2A ), indicating that CSFV infection is necessary for the induction of Akt/mTORC1 inhibition. Importantly, we further confirmed that rapamycin significantly increased, and insulin decreased, the expression of CSFV proteins (Core and N pro ) at 24 hr p.i. (Figure 2B ). In parallel, the intracellular CSFV-RNA replication and extracellular virus production were examined, with results consistent with the western blot data ( Figures 2C and 2D ). To exclude the influence of cell numbers on virus copies and load, we determined cell growth inhibition after exposing to diverse treatments as mentioned above. The results showed that increased virus levels were found in decreased numbers of cells in the rapamycin treatment group, whereas decreased virus levels were found in elevated cell numbers in the insulin treatment group ( Figure 2E ). This positively excludes the influence of cell numbers on virus production and indicates that activation of the Akt/TSC2/mTORC1 pathway effectively inhibits CSFV replication and virus production.
We further evaluated the impact of mTORC1 on CSFV replication by enhancing the activity of mTORC1. This was achieved by inhibiting the expression of the gene tuberous sclerosis 2 (TSC2) by TSC2-short hairpin RNA (shRNA), a physiologic inhibitor of mTORC1 (Sengupta et al., 2010) . As shown in Figure 2E , the phosphorylation of S6, as the key downstream indicator of mTORC1 signaling activity, was significantly inhibited upon the potent inhibition of TSC2 (see Figure S2 for quantified protein bands of TSC2 and phospho-S6). Also as expected, the CSFV gene copies were significantly decreased at 24 hr p.i. when compared with control at both intra-and extracellular levels.
Intriguingly, as shown in Figures 2B-2D , rapamycin and insulin both had significant effects in regulating the expression of CSFV proteins, CSFV copies, and viral titers within the first 24 hr p.i, but these had disappeared by 48 hr p.i. According to the results in Figure 2F , the cells in the rapamycin-treated group were significantly fewer than those following insulin treatment at 48 hr, which might be ascribed, at least in part, to the inconsistent cell numbers following the different treatments. Alternatively, we speculated whether CSFV-induced mTORC1 inhibition might elicit the feedback activation of Akt, which would facilitate mTORC1 activation and result in loss of the ability to promote viral replication. To determine if mTORC1-inhibition-induced Akt feedback activation is indeed involved in CSFV-infected cells, an Akt-specific inhibitor (LY294002) was used. As shown in Figure 2G , LY294002 potently enhanced CSFV RNA copy numbers. More importantly, the efficacy of LY294002 was much stronger than that of rapamycin ( Figure 2C ) with the effect persistent over the entire 72 hr p.i. Conversely, Akt activator SC79 significantly suppressed the CSFV RNA copies at all time intervals ( Figure 2H ). These results positively support our hypothesis that CSFV-induced mTORC1 inhibition elicits the feedback activation of Akt, which contributes to viral replication. Altogether, these results provide evidence for the involvement of Akt/TSC2/mTORC1 as an anti-viral mechanism within the context of CSFV infection.
CSFV Infection Induces Cellular Autophagy in an mTOR/ULK1-Dependent Manner
Autophagy has been reported to enhance the replication of CSFV; however, the underlying mechanisms remained unclear. The above-mentioned results indicated that CSFV infection dysregulated the mTORC1pathway, noting that mTOR could act as a regulator of autophagy in several cell lines. We then clarified whether CSFV infection induces autophagy in a manner dependent on mTOR. The specific autophagy markers and autophagy flux were detected in CSFV-infected cells by western blot and the stubRFP-SensGFP-LC3 lentivirus. As expected, the expression of LC3II increased from 4 hr to 12 hr p.i., and then decreased to the base level. Correspondingly, the level of SQSTM1/p62 (the substrate of autophagy) decreased between 4 hr and 12 hr p.i. in CSFV-infected cells, and then began to recover ( Figure 3A ). In parallel, we observed that CSFV induced the accumulation of cytoplasmic autophagosomes (RFP + GFP + [red fluorescent protein, green fluorescent protein, respectively]) at 12 hr p.i., following which the autophagosomes began to fuse with the lysosomes. An abundance of autolysosomes (RFP + GFP À ) had formed by 24 hr p.i., as GFP fluorescence declined upon lysosomal acidification (with reduced pH values), whereas RFP fluorescence remained stable ( Figure 3B ). These data show that CSFV indeed induces an integrated autophagic process.
We then examined whether the mTORC1 pathway contributes to CSFV-infection-induced autophagy. With regard to this, ULK1 is the key downstream kinase that connects the mTOR pathway and autophagy, with dephosphorylation being the activated status of ULK1 and promoting the autophagy process by recruiting Atg12 and FIP200 to form a complex. As indicated in Figure 3C , the alteration of phosphorylated mTORC1 and ULK1 negatively correlated with the process of autophagy, i.e., CSFV infection dephosphorylated mTORC1 and ULK1, thereby promoting autophagy. To further clarify whether mTORC1/ULK1 pathway regulates CSFV-induced autophagy, the process was examined in CSFV-infected ST cells with mTORC1 inhibition or activation. As shown in Figure 3D , inhibition of mTORC1 by rapamycin synergistically enhanced CSFV-induced autophagy, whereas activation of mTORC1 with insulin reversed CSFV-induced autophagy. A similar outcome was observed by transducing stubRFP-SensGFP-LC3 lentivirus into ST cells in the presence of rapamycin, insulin, or ULK1 inhibitor SBI-0206965 (which works as a specific inhibitor of ULK1 to block the formation of the Atg13/FIP200/ULK1 autophagy complex) (Egan et al., 2015; Petherick et al., 2015) . Autophagy was potently increased when mTORC1 was inhibited by rapamycin, but diminished when it was activated by insulin or when the ULK1-induced autophagy complex was blocked by SBI-0206965 ( Figure 3E ).
Further experiments were performed to confirm that CSFV-induced autophagy promoted viral replication in a manner dependent on mTORC1/ULK1. As shown in Figures 3F-3H , after blockage of ULK-1 by SBI-0206965, not only the production of CSFV core protein but also the viral gene copies and virus titers were inhibited at 24-48 hr p.i. both intra-and extracellularly, whereas cell growth was not influenced by SBI-0206965 (500 nM) treatment with or without CSFV infection ( Figure 3I ), thereby excluding the possibility that cell numbers affected viral copies. Altogether, these results show that CSFV induced autophagy in an mTORC1/ULK1-dependent manner, which facilitated viral replication.
To study the importance of mTORC1-dependent autophagy in CSFV replication, we assessed viral replication in ST cells deficient in key autophagy gene Atg5 (autophagy-related gene 5). Interestingly, the autophagy-deficient cells still exhibited increased viral replication following rapamycin treatment, although the increase was reduced when compared with normal control ST cells ( Figure 3J ). The conclusion is that although mTORC1-dependent autophagy indeed plays a key role in viral replication, there still exist some other mechanism(s) apart from autography contributing to mTORC1-inhibition-induced viral replication in CSFV-infected cells.
CSFV Infection Improves the Translation of Viral Proteins in an mTORC1/S6K1/eIF3-Dependent Manner
Previous studies have shown that HCV-IRES and eIF3 can competitively gain access to the 40S ribosomal subunit, thereby regulating the translation of viral mRNA (Hashem et al., 2013) , and that S6K1 can interact with the eIF3 complex (Schepetilnikov et al., 2013) . We therefore hypothesized that CSFV-induced mTORC1 inhibition could promote association between S6K1 and the eIF3 complex, resulting in the release of eIF3 from the 40S subunit and promoting the specific interaction between CSFV-IRES and the 40S subunit, thereby facilitating translation of viral proteins and enhancing CSFV replication.
To examine how S6K1 regulates the translation of viral proteins by manipulating the activity of CSFV-IRES, S6K1 knockdown (S6K1-KD), and S6K1 over-activation (S6K1-Over; mutant Thr229/Thr389/Ser371) ST cell lines were established. As shown in Figure 4A , the phosphorylation of S6K1 was significantly decreased in S6K1-KD ST cells and increased in S6K1-Over cells. Activity of CSFV-IRES was then monitored by constructing a reporter CSFV-5 0 UTR (IRES included)-encoding luciferase under the control of the genomic promoter (IRES-Luc; Figure 4B , upper). Strikingly, the luciferase activity of CSFV-IRES was increased by 33.9% in S6K1-KD cells, but decreased by 30.2% in S6K1-Over ST cells when compared with the negative control ( Figure 4B, lower) . Determination of viral gene copies and viral titers at 24 hr p.i. provided results consistent with the activity of CSFV-IRES: overexpression of activated S6K1 resulted in a decrease, whereas knockdown of S6K1 increased the viral gene copies and titers both intra-and extracellularly ( Figures 4C and 4D ).
To clarify that the inactivated S6K1 promoted the activity of CSFV-IRES by releasing its binding with eIF3 complex, the interaction between S6K1 and eIF3 was determined in CSFV-infected cells by co-immunoprecipitation. As shown in Figure 4E , CSFV infection inhibited the phosphorylation of S6K1 and enhanced S6K1 interaction with eIF3A.
In addition, we examined whether CSFV-induced inhibition of mTORC1 releases the 40S ribosome-binding site of eIF3, thereby enhancing the specific interaction between CSFV-IRES and 40S ribosome. Ribosomes were isolated from ST cells treated with rapamycin or insulin and incubated with CSFV for 24 hr. The fraction-specific proteins of ribosomes and virus were then assessed to determine the purity of ribosomes. As shown in Figure 4F , ribosomal proteins S12 (RPS12) and S6 were detected only in the bottom pellet, whereas the viral core protein was detected exclusively in the supernatant. Importantly, inhibition of mTORC1 by rapamycin enhanced CSFV-IRES ribosomal binding and insulin released the binding between ribosome and CSFV-IRES ( Figure 4G ), which strongly supports the conclusion that rapamycin promoted and insulin inhibited the translation of CSFV-mRNA. To further ensure that the binding of ribosomes to IRES copies was not contaminated by residual virus particles, virus distribution in the supernatant and ribosome pellet was monitored by immunofluorescence assay. As shown in Figure 4H , abundant viruses were observed in the supernatant and virus distribution showed a pattern consistent with that found above, i.e., more viruses were observed following rapamycin treatment, and less following insulin treatment, when compared with the untreated control. However, in ribosome pellets isolated from cells receiving either treatment, only one or two virus plaques (green dots) were observed in each well, with no differences in plaque numbers among the three groups ( Figure 4H ). The possibility of artifactual cross virus contamination was therefore eliminated, and the data show that CSFV-induced inactivation of mTORC1/S6K1 promoted non-cap-dependent translation of viral mRNA by increasing S6K1/eIF3 binding, relieving competition between eIF3 and CSFV-IRES for a common binding site on the 40S subunit and thereby favoring translation of viral mRNA ( Figure 4I ). 
CSFV-Mediated Inhibition of mTORC1 Equilibrates Viral Replication and Cell Survival by Eliciting the Feedback Activation of Akt Kinase
The above-mentioned studies have indicated that CSFV-induced mTORC1 inhibition failed to induce cell growth inhibition and apoptosis ( Figure 2F ) and, importantly, that a rebound in mTORC1 levels was followed by a decrease ( Figure 1B) . Considering the similar phenomenon in cancer research (Sun et al., 2005; Wang et al., 2008) , we hypothesized that temporary inhibition of mTORC1 induced by CSFV might stimulate the feedback activation of Akt/mTORC1, contributing to viral replication and cell survival.
The two phosphorylation sites of Akt kinase were examined to define whether Akt could be re-activated in CSFV-infected cells. As shown in Figure 5A , phosphorylation of both Akt (Thr308) (which usually acts as an effector of mTORC1) and Akt (Ser473) (acts upon mTORC2) was potently inhibited following CSFV infection, although strikingly, the inhibition was transient, with a low at 8-12 hr p.i., rebounding to the basal level by 48 hr p.i. Importantly, the alteration of phosphor-Akt was consistent with that affecting downstream effectors, including S6 and mTORC1 ( Figures 1A and 1B) .
To investigate the role of Akt/mTORC1 feedback activation in maintaining cell survival in CSFV-infected cells, ST cells were incubated with its specific inhibitor LY294002 or CSFV (active and UV-inactive) alone, or with LY294002 for 2 hr before viral infection with CSFV at 1 MOI (multiplicity of infection) for 48 h. As shown in Figure 5B , both active and UV-inactivated CSFV had little effect on cell growth (<5%), whereas LY294002 (1 mM) inhibited cell growth by 13.3% and the combination of CSFV and LY294002 caused a potent growth inhibition of up to 30.5%. In parallel, the level of Akt phosphorylation was determined at each treatment ( Figure 5B, lower) , showing that inhibition of PI3K/Akt feedback activation resulted in a synergetic cell growth inhibition when compared with CSFV or LY294002 alone.
Furthermore, cell cycle and cell apoptosis analyses were performed to confirm the role of Akt feedback activation in maintaining cell homeostasis. As shown in Figure 5C , CSFV induced a cell-cycle arrest in the G0/G1 phase within 24 hr (from 72.6% to 77.2%), while effectively releasing the cell cycle by 48 hr, during which time period the G0/G1 phase decreased from 84.6% to 70.2%, whereas the S phase increased from 11.0% to 23.0%, indicating a rebound of the cell cycle. Importantly, after blockage of Akt by LY294002, the cell cycle did not return to the level without Akt blockage (S phase: 14.27% versus 22.95%). In parallel, we examined cell apoptosis after infection with CSFV for 48 hr in the presence or absence of LY294002. As shown in Figure 5D , treatment with CSFV or LY294002 separately induced cell apoptosis of 0.71% or 2.06%, respectively; however, their combination induced a synergetic apoptosis of 6.16%. TUNEL assay also confirmed this synergetic efficacy ( Figure 5E ). All the above-mentioned results are consistent with the conclusion that CSFV-induced Akt feedback activation indeed played a key role in rescuing the cell and that blockage of Akt resulted in the synergistic inhibition of the cell cycle and induction of cell apoptosis in CSFV-infected cells.
To clarify the influence of Akt/mTORC1 feedback activation on viral replication, viral gene copy numbers were determined in the presence or absence of LY294002. Results showed that blockage of Akt activity increased the virus copies in infected cells continuously from 24 to 96 hr when compared with CSFV treatment ( Figure 5F ). This confirmed that Akt persistent inhibition promotes viral replication, which also indicates that CSFV-induced Akt/mTORC1 negative feedback activation indeed contributed to maintaining viral copy numbers at a stable level rather than increasing.
DISCUSSION
As a sensor of cellular homeostasis, mTOR activity is often perturbed during viral infection. For instance, envelope protein E2 of HCV suppresses the activation of Akt/mTORC1 by inducing ER stress (Wang et al., 1999) , vaccinia virus (VACV) induces the activation of PI3K/Akt/mTOR via lipid rafts, and vesicular stomatitis virus (VSV) induces hypophosphorylation of Akt, resulting in the inhibition of GSK3b and mTOR and promotion of viral replication (Dunn and Connor, 2011) . In our study, we found that several CSFV proteins, E rns , NS3, and NS5A, were involved in inhibiting the activation of both mTORC1
and Akt kinase, whereas E2 had the reverse function of moderately inducing the activation of Akt/ mTORC1. Accordingly, we concluded that different viral proteins were likely to hijack diverse signaling pathways to support cell survival and viral replication, and undoubtedly, Akt/mTORC1 was an important one. The mTOR pathway has been identified as being involving in diverse biological functions, such as cell survival, autophagy, energy metabolism, and biosynthesis. Herein, we focused on exploring the mechanism by which mTORC1 contributes to the regulation of the replication of CSFV. Autophagy has been implicated in viral replication by providing intracellular membrane structures or by maintaining intracellular homeostasis (Miller and Krijnse-Locker, 2008) . For example, measles virus (MeV) induces autophagy to prevent cell death and promote proliferation of progeny virions (Richetta et al., 2013) , HCV induces complete autolysosome formation for viral replication by repressing the innate immune response (Ke and Chen, 2011) , and human parainfluenza virus type 3 (HPIV3) infection induces the accumulation of cytoplasmic autophagosomes by direct inhibition of autolysosome formation, resulting in an increase of viral production (Ding et al., 2014) . CSFV NS5A and E2 have been reported to induce autophagy during viral replication . Paradoxically, virus-induced autophagy can also serve as a mechanism of host defense by favoring cell survival and thereby restricting viral replication, as with CHIKV and HIV-1; both could cause the subversion of autophagy to facilitate new virion production (Kyei et al., 2009; Joubert et al., 2012) . Our results clarified that CSFV infection induces a complete autophagy process that involves not only autophagosome formation but also an increasing autophagic flux in host cells for viral replication.
To further confirm that autophagy in CSFV-infected cells is induced by an mTORC1/ULK1-dependent pathway, and that it is indeed necessary for viral replication, we blocked activation of ULK1, the key hub connecting mTOR pathway and autophagy. Our results showed that viral replication was significantly inhibited following ULK1 inhibition and the resulting diminished autophagy, which strongly indicates that CSFV induces autophagy in an mTORC1/ULK1-dependent manner, with this autophagy playing a key role in promoting CSFV replication.
In addition to being a regulator of autophagy, mTORC1 also acts as a regulator of protein translation via its downstream effectors, such as 4E-binding proteins (4E-BPs) or S6K1. We have presented evidence that mTORC1 inhibition acts to increase viral replication in Atg5-silenced cells and that the inhibition efficacy of Akt/mTORC1 activator (insulin) to CSFV replication is more potent than that of autophagy blockage. We questioned, therefore, whether mTORC1 contributes to CSFV replication by other mechanism(s) than autophagy, such as involving other downstream effectors of Akt/mTORC1 pathway that may promote CSFV viral replication.
A major function of mTORC1 is to initiate cap-dependent translation by directly phosphorylating 4E-BPs and S6K1, and the inhibitory effect of mTORC1 inhibitors (rapalogs) on viral replication has been well documented in instances in which the virus possesses capped mRNA (Bose et al., 2012; McNulty et al., 2013) . However, whether mTORC1 facilitates the replication of viruses without a capped mRNA, such as HCV or CSFV, remained uncertain. Some viruses have evolved alternative mechanisms to bypass cellular programs that limit the ribosomal machinery and facilitate viral protein translation, including the use of IRES, ribosome shunting, and the substitution of VPg for the mRNA cap (Leen et al., 2016) , which permit efficient replication in the absence of cap-dependent initiation protein eIF4E. IRES-mediated translation has the advantage for viruses with such a domain since viral proteins can continue to be generated efficiently even in cells undergoing apoptosis or nutrient starvation.
Many of the mysteries of how mTORC1 and S6K1 exert their control over translation of CSFV mRNA are now much closer to being solved. Previous studies have found a 40S ribosome complex containing eIF3 and CSFV-IRES, in which eIF3 has been completely displaced from its ribosomal position in the 43S complex (Hashem et al., 2013) . Holz et al. (46) then demonstrated that eIF3 family members, as S6K1 interactors, represented a potential important connection between the mTOR pathway and an integral component of the translational pre-initiation apparatus, with the activity of S6K1 negatively regulating its binding to eIF3. For example, the mutants that eliminate S6K1 activity constitutively bound eIF3, whereas active S6K1 mutants were incapable of this (Holz et al., 2005) . Therefore, we hypothesized that CSFV-induced hypophosphorylation of S6K1 at mTORC1-specific residue T449 would promote its interaction with eIF3, thereby releasing the 40S ribosome binding site for CSFV-IRES and facilitating viral replication. Our results have demonstrated that S6K1 was indeed hypophosphorylated following CSFV-induced mTORC1 inhibition, which increased the binding between inactivated S6K1 and eIF3A (a key subunit of eIF3), whereas interaction between S6K1 and the 40S ribosome was decreased and interaction between CSFV-IRES and 40S ribosome was increased, resulting in enhancement of virus production. These data imply that translation of host cell mRNA might be inhibited and translation of viral mRNA might be enhanced when mTORC1 is inhibited by invasive viruses. Furthermore, two interesting phenomena were observed following CSFVinduced mTORC1 inhibition: on the one hand, infected cells maintained survival with no increase in cellular apoptosis (see Figures 5B-5D) , and on the other, rapamycin induced a significant increase in CSFV viral replication, although this enhancement was lost by 48 hr p.i.
Inhibition of mTORC1 by rapalogs fails to induce significant cell growth inhibition and cell apoptosis in almost all kinds of tumor cells, and several mechanisms have been uncovered to counteract their anti-cancer efficacy; for example, rapalogs block S6K1-IRS1 negative feedback loop, leading to the activation of PI3K/ Akt prosurvival signals (O'reilly et al., 2006) , or they increase eIF4E phosphorylation through an MnK-dependent mechanism, thereby promoting cell survival and apoptotic resistance (Sun et al., 2005) . Intriguingly, we found that CSFV induced temporary inhibition of Akt activity at both Ser473 and Thr308 sites within the first 12 hr, following which Akt/mTORC1 is feedback activated ( Figure 5A ). We then speculated whether CSFV infection induced the feedback activation would contribute to inhibiting cell apoptosis and limiting viral replication. Akt was blocked by LY294002 in ST cells, and the results indicated that CSFV rapidly accelerated cell cycle into the S phase, whereas the G0/G1 release was diminished. This provides strong evidence that Akt was reactivated and released the cell cycle. Moreover, blockage of Akt synergistically inhibits cell growth and promotes cell apoptosis when compared with CSFV or LY294002 mono-treatment. In addition to elucidating the role of Akt feedback activation in maintaining cell survival, its effect on viral replication was determined. When Akt was blocked, the virus copy numbers increased continuously from 24 hr to 96 hr when compared with CSFV infection alone. All these results provide strong evidence that CSFV-induced mTORC1 inhibition induces Akt feedback activation, thereby maintaining equilibrium between cell survival and viral replication. Indeed, feedback-like activation mechanisms have been noted in several viruses; for example, HSV-1 Us3 virus kinase stimulates Akt and induces the activation of mTOR, which avoids S6K-mediated feedback activation, thereby maintaining Akt activation and viral replication (Naghavi et al., 2013) . Influenza A virus induces transient PI3K and mTORC1 activity for regulating cell survival and virus production in an autophagy-dependent manner (Datan et al., 2014) . In addition, PRRSV infection has been found to increase phosphorylation of mTOR at early stage, followed by a decrease (Zhang and Wang, 2010) ; although the mechanism has not been elucidated, it might be associated with Akt feedback activation.
In summary, our study has determined that CSFV infection induces the hypophosphorylation of mTORC1, and furthermore, we have provided evidence for a novel mechanism by which CSFV responds to mTORC1 inhibition, resulting in a more favorable environment for viral replication via mTORC1/ULK1-dependent autophagy and mTORC1/S6K1/eIF3-mediated translation of viral mRNA. We have also provided evidence that CSFV-induced mTORC1 inhibition elicits Akt/mTORC1 negative feedback activation, thereby maintaining intracellular homeostasis of cell survival and viral replication. Our study provides new insights into the mechanisms of CSFV replication and may suggest new therapies for the treatment of classical swine fever disease.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. 
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Transparent Methods
Cell lines, virus strains and plasmids
The swine testis cell line (ST) was cultured in complete Dulbecco's modified Eagle's medium (DMEM) (Corning, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Corning) and 1% antibiotics, and incubated at 37℃ in 5% CO 2 .
UV-inactivated CSFV was obtained by irradiating Shimen strain (maintained in our laboratory, GenBank accession No. AY775178) with UV light for 45 min at room temperature, the lack of infectivity of UV-inactivated CSFV was confirmed as described 
Cell culture and titration of CSFV
ST cells in 96-well plates were incubated with 10-fold serial dilutions of CSFV and cultured for 3 days, then fixed in 80% cold acetone in PBS, washed and incubated with CSFV E2 protein-specific monoclonal antibody WH303 (Lin et al., 2000) .
Following further washing with phosphate-buffered saline with Tween 20 (PBST), FITC-conjugated goat anti-mouse IgG (Sigma-Aldrich) was added and incubated for 1 h at 37℃. Subsequently, cells were washed twice with PBST and cell nuclei were stained with DAPI for fluorescence microscopical examination. Virus titers were calculated according to Kä rber and expressed as TCID 50 /ml (Gong et al., 2016) .
Viral infection and drug treatment
When reaching approximately 80% confluence, ST cells were infected with CSFV at 1 MOI. Virus titers were determined as described above. Briefly, after 1 h incubation at 37℃, the inoculum was removed, the cells were then washed twice with PBS and incubated in complete MEM. For drug treatment, cells were pretreated with insulin (1μM), rapamycin (100 nM), LY294002 (1μM), SC79 (1μM) or SBI-0206965 (500 nM) for 2 h. The inocula were then removed and cells were washed twice with PBS, followed by a 1 h incubation with CSFV at 37℃. Finally, the cells were washed twice with PBS and incubated in complete MEM with drugs for different times until harvesting.
Intracellular signaling membrane array
To analyze the influence of CSFV infection on the activity of Akt/mTOR signaling pathway, ST cells were infected with CSFV at 1MOI for 12-48 h at 37℃, then lysed and assayed using the PathScan® Intracellular Signaling Membrane Array Kit (Cell Signaling Technology, #14471) according to the manufacturer's instructions. The membranes were scanned using an LAS4000 Luminescent Image Analyzer (Fujifilm, Japan).
Western blotting
Cells were lysed in lysis buffer (Cell Signaling Technology) containing protease inhibitor cocktail (Thermo Fisher Scientific). The lysates were centrifuged at 13,000g
for 20 min and the protein was quantified by a bicinchoninic acid (BCA) protein assay.
Equal protein samples were subjected to SDS-PAGE and transferred onto nitrocellulose blotting membranes. After blocking with LI-COR Odyssey Blocking
Buffer (LI-COR Biosciences) for 2 h at room temperature, the membranes were incubated with primary antibody at 4℃ overnight, followed by incubation with AlexaFluor-680 labeled secondary antibodies for 1 h as described above. Finally, membranes were scanned using an Odyssey Infrared Imaging System (LI-COR Biosciences, USA).
Autophagy flow detection system
ST cells were grown to approximately 40% confluence in 6-well plates and were infected with StubRFP-Sens GFP-LC3 lentivirus (MOI = 0.1). Three days later, the cells were infected with CSFV at 1 MOI for 12 h or 24 h for autophagy induction.
Cells then were fixed with 4% paraformaldehyde for 30min and nuclei were stained with DAPI. Autophagosome-like vesicles were examined using a Zeiss LSM 780 confocal microscope (Zeiss, Germany).
Real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
Viral RNA was extracted using viral RNA Kit (Tiangen), and the synthesis of cDNA was performed using the Eastep® RT Master Mix Kit (Promega) according to the manufacturers' protocols. For CSFV-specific detection, the primers targeting a region corresponding to the CSFV 5'-untranslated regions (5'-UTR) were as previously described (Shi et al., 2009) . Reactions were performed using TaqMan probes according to a previously described method in the Strata-gene MX3000P qPCR system (Agilent, USA) (Shi et al., 2013) . The recombinant plasmid containing the CSFV 5'-UTR was used to construct a standard curve for calculating virus gene copies.
Dual-luciferase reporter Assay
The dual luciferase reporter vector was constructed by synthesizing the seed sequence in the 5'-UTR of CSFV Shimen strain (forward primer 5'-TGCAG GATAT CGTAT ACGAG GTTAG TTC-3' and reverse primer 5'-CCCAA GCTTG TGCCA TGTAC AGCAG A-3') and inserting the annealed products into the pGL4.20 [luc2/Puro] vector (Promega, Madison, USA) at EcoRV and HindII enzyme sites (pGL-IRES).
Stable ST-S6K1-overexpression and ST-S6K1-KD cell lines were established using their specific plasmids, with selection by culture in G418 (400 μg/ml), and were continually passaged at low density to allow for selection of subclones with acquired G418 resistance. The established cells were transfected with recombinant pGL-IRES, then lysed after 24 h and luciferase activities were determined using a dual-Luciferase® reporter assay system (Promega, E1910) and luminometer (GloMax® 20/20 Single Tube Luminometer, Promega, USA). The pGL4.74
[hRluc/TK] (Promega) vector was used as control with the ratio firefly/Renilla taken as representing the activity of CSFV-IRES.
Co-immunoprecipitation (Co-IP)
ST cells were infected with CSFV and treated with rapamycin (500 nM) or insulin (1μM) as described above, and harvested at 24 h p.i.(post-infection). The Co-IP assay was performed using a Pierce™ Classic Magnetic Co-IP Kit (Thermo Fisher Scientific, 88804) according to the manufacturer's instructions. Briefly the cells were lysed for 5 min on ice after washing, followed by centrifugation at 13,000×g for 10 min at 4℃. The lysates were incubated overnight at 4℃ in a rotator with rabbit anti-p70S6K antibody or anti-eIF3A antibody, with normal rabbit IgG antibody being used as a negative control. Twenty-five μl pre-washed magnetic protein A/G beads were added and incubation continued for 4 h at room temperature with constant rocking. The beads were then gently spun down and washed three times with PBS, then boiled and collected with a magnetic stand. Proteins in the supernatant were separated on SDS-PAGE and examined by Western blotting.
Cell ribosome isolation and quantification of CSFV-IRES
To analysis the copies of CSFV-IRES binding in the ribosomal 40S subunit, ST cells were grown in 10 cm plates and treated with the appropriate virus and reagents for 24 h, then collected for cellular ribosome isolation using the Animal Cell Ribosome
Isolation Kit (Genmed Scientifics Inc. USA; GMS10409.1) according to the manufacturer's instructions. In brief, cells were collected and lysed on ice for 10 min, then centrifuged at 13,000g, at 4℃ for 10 min. Supernatants were then transferred into 15 ml tubes and carefully mixed with 4 ml of GENMED separation solution.
Four ml aliquots were then transferred to an 8 ml centrifuge tube and centrifuged at 260,000g at 4℃ for 2h, following which the supernatant was discarded and the pellets (ribosomes) were resuspended in 1ml GENMED storage solution. To analyze CSFV-IRES/ribosome binding, RNA was extracted and quantified, and copies of CSFV-IRES were determined by RT-qPCR as described above.
Cell viability assay
Cell viability was determined by sulforhodamine B (SRB) assay. In brief, 96-well plates were seeded with ST cells at 6 ×10 3 per well in and allowed to grow overnight.
Cells were treated with appropriate virus and reagents for 48 h or 72 h. Surviving cells were determined using the SRB assay as published (Vichai and Kirtikara, 2006) .
Growth inhibition was determined using the equation: % growth inhibition = (1 -At/Ac) × 100, where At and Ac represent the absorbance in treated and control cultures, respectively, as described previously (9).
Flow cytometry
For cell cycle analysis, cells were synchronized by growing in serum-free medium for 48 h and released into the cell cycle by adding 10% FBS to the medium. The cells were treated with appropriate virus and reagents for 24 h or 48 h, fixed with 70%
ethanol, and stained with PI. To analyze apoptosis, cells were suspended in binding buffer, stained with annexin V and PI (BD Biosciences), incubated for 15 min in the dark and subjected to flow cytometry analysis. All data were acquired by FACScan (BD Biosciences) and analyzed using FlowJo software (Tree Star Inc. USA).
TUNEL analysis
TUNEL assay was performed on ST cells using the One
Step TUNEL apoptosis assay kit according to the manufacturer's instructions. ST cells were fixed with 4% paraformaldehyde and 0.3% Triton X-100 after treatment with CSFV or LY294002
for 48 h, then samples were incubated with TUNEL reaction mixture for 1 h at 37℃
in the dark and washed twice with PBS. Following staining with DAPI, proportions of condensed or fragmented nuclei of apoptotic cells were determined using fluorescence microscopy at ×10 magnification.
Statistical analysis
All statistical analyses were performed using GraphPad Prism software (San Diego, USA). Data are presented as mean value ± standard error, and the clinicopathological parameters were compared using Fisher's exact test. Statistical significance of differences between the two groups was analyzed using the two-tailed unpaired
